Gene: SRD5A1
Official Full Name: steroid 5 alpha-reductase 1provided by HGNC
Gene Summary: Steroid 5-alpha-reductase (EC 1.3.99.5) catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone (DHT). Also see SRD5A2 (MIM 607306).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05226 | SRD5A1 Knockout cell line (HeLa) | Human | SRD5A1 | 1:3~1:6 | Negative | Online Inquiry |
KO05227 | SRD5A1 Knockout cell line (HCT 116) | Human | SRD5A1 | 1:2~1:4 | Negative | Online Inquiry |
KO05228 | SRD5A1 Knockout cell line (HEK293) | Human | SRD5A1 | 1:3~1:6 | Negative | Online Inquiry |
KO05229 | SRD5A1 Knockout cell line (A549) | Human | SRD5A1 | 1:3~1:4 | Negative | Online Inquiry |
SRD5A1 Gene Knockout Cell Lines are specialized cellular models designed to lack the expression of the SRD5A1 gene, which encodes the enzyme steroid 5α-reductase type 1. This enzyme plays a critical role in the conversion of testosterone into dihydrotestosterone (DHT), a potent androgen implicated in a variety of physiological and pathological processes, including hair loss, prostate growth, and metabolic disorders. By utilizing SRD5A1 knockout cell lines, researchers can effectively study the biological effects of androgens, investigate the role of SRD5A1 in disease models, and assess therapeutic interventions targeting androgen-mediated pathways.
The mechanism underlying the utility of these cell lines lies in their ability to provide a controlled environment for research into androgen signaling pathways. Without SRD5A1, these cell lines exhibit altered hormonal responses, allowing for the exploration of DHT's impact on cellular processes such as proliferation, differentiation, and apoptosis. This makes SRD5A1 knockout cell lines invaluable in both basic research and drug development, particularly in studies focused on hormonal influence in various diseases, including androgen-dependent cancers.
Scientific research increasingly emphasizes the importance of model systems that accurately mimic disease states. SRD5A1 knockout cell lines enable researchers to conduct targeted studies that yield insights into the biological underpinnings of conditions influenced by androgens. In clinical settings, such insights can inform therapeutic strategies for conditions like benign prostatic hyperplasia and androgenic alopecia, enhancing patient care through the development of more effective treatments.
Compared to traditional cell lines that express SRD5A1, these knockout models offer a distinct advantage in specificity for studying the isolated role of DHT and the consequent biological effects. The precision of these tools allows researchers to navigate complexities in androgen signaling with greater accuracy, delivering results that can lead to more meaningful clinical applications.
For researchers, clinicians, and pharmaceutical developers, SRD5A1 Gene Knockout Cell Lines are essential components of a robust research toolkit. They represent an innovative approach to understanding androgen-related mechanisms in health and disease. Our company is dedicated to advancing scientific research by providing high-quality biological products such as these knockout cell lines, designed with precision and rigor to support groundbreaking discoveries in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.